Quick Answer
Sensei Biotherapeutics, Inc. reported Shares Outstanding of 1.26 million shares for fiscal year 2025.
Sensei Biotherapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.26M | +0.2% |
| 2024 | 1.26M | -95.0% |
| 2023 | 25.03M | -18.6% |
| 2022 | 30.76M | +0.5% |
| 2021 | 30.61M | +1532.1% |
| 2020 | 1.88M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.26M | -95.0% | +0.0% |
| June 30, 2025 | 1.26M | -95.0% | -95.0% |
| March 31, 2025 | 25.21M | +0.5% | +1902.3% |
| December 31, 2024 | 1.26M | -95.0% | -95.0% |
| September 30, 2024 | 25.15M | +0.6% | +0.1% |
| June 30, 2024 | 25.12M | -5.5% | +0.2% |
| March 31, 2024 | 25.07M | -19.0% | +0.2% |
| December 31, 2023 | 25.03M | -18.6% | +0.1% |
- Sensei Biotherapeutics, Inc. showed an increase of +0.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Sensei Biotherapeutics, Inc.’s shares outstanding has declined by 32.7% (from 1.88 million shares to 1.26 million shares).
- The most recent figure is from Sensei Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: